1.25
-0.02(-1.57%)
Currency In USD
| Previous Close | 1.27 |
| Open | 1.27 |
| Day High | 1.29 |
| Day Low | 1.24 |
| 52-Week High | 2.72 |
| 52-Week Low | 0.85 |
| Volume | 2.43M |
| Average Volume | 8.22M |
| Market Cap | 375.46M |
| PE | -0.56 |
| EPS | -2.23 |
| Moving Average 50 Days | 1.39 |
| Moving Average 200 Days | 1.44 |
| Change | -0.02 |
If you invested $1000 in Pacific Biosciences of California, Inc. (PACB) 10 years ago, it would be worth $255.1 as of September 08, 2025 at a share price of $1.25. Whereas If you bought $1000 worth of Pacific Biosciences of California, Inc. (PACB) shares 5 years ago, it would be worth $192.01 as of September 08, 2025 at a share price of $1.25.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
PacBio and EpiCypher Partner to Deliver Novel Insights into Epigenomics with Fiber-seq Workflow
GlobeNewswire Inc.
Sep 03, 2025 1:05 PM GMT
New addition to PacBio Compatible program enables scientists to connect genetic variation with gene regulation in a single assay, advancing research in rare disease and cancerMENLO PARK, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PA
Nature Methods Paper Leverages PacBio Sequencing Technology to Develop the Platinum Pedigree Benchmark, a New Standard for Accurate Characterization of Variation in the Human Genome that Improves Training for AI Models
GlobeNewswire Inc.
Aug 04, 2025 1:05 PM GMT
The most comprehensive, family-based variant dataset ever published will improve variant classification using AI-based toolsMENLO PARK, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accu
PacBio HiFi Sequencing Powers First Arab Human Pangenome, Published in Nature Communications
GlobeNewswire Inc.
Jul 24, 2025 1:05 PM GMT
Study reveals millions of previously unknown variants and genomic sequences from underrepresented populationsMENLO PARK, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencin